Literature DB >> 28188751

Immunohistochemical study of mucins in human intestinal spirochetosis.

Sho Ogata1, Ken Shimizu2, Susumu Tominaga3, Kuniaki Nakanishi4.   

Abstract

Most patients with human intestinal spirochetosis (HIS; a colorectal bacterial infection caused by Brachyspira species) seem asymptomatic, and its pathogenicity remains unclear. Recently, alterations in mucin expression were reported in animal Brachyspira infection. The present question was "Is mucin expression altered in HIS?" Using antibodies for MUCs 1, 2, 4, 5AC, and 6, we immunohistochemically compared 215 specimens from 83 histology-confirmed HIS cases with 106 specimens from 26 non-HIS cases. Positive staining (which included even focal positive staining) was rated "high (+)" or "low (+)." Results were analyzed for 4 categories of lesions, and associations between MUC expression and spirochetal presence were also analyzed. In the "specimens without polyps or adenocarcinoma" category, high (+) MUC2 positivity was more frequent in HIS than in control. In the hyperplasia/serrated polyp category, in HIS (versus control), the MUC5AC positivity rate was lower, whereas high (+) MUC4 positivity was more frequent. In the conventional adenoma category, in HIS (versus control), the MUC1 positivity rate was lower, whereas both high (+) MUC2 positivity and high (+) MUC5AC positivity were less frequent. In the adenocarcinoma category, high (+) MUC2 positivity was more frequent in HIS than in control. Among the above mucins, only MUC1 positivity was significantly associated with an absence of the so-called fringe formation, an absence of spiral organisms within mucus, and an absence of strong immunopositive materials within the epithelial layer and within the subepithelial layer. The results suggest that Brachyspira infection or a related change in the microbiome may alter the large intestine mucin expression profile in humans.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brachyspira; Human intestinal spirochetosis; Immunohistochemistry; Mucin; Spirochetosis

Mesh:

Substances:

Year:  2017        PMID: 28188751     DOI: 10.1016/j.humpath.2017.01.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

Review 1.  The Spirochete Brachyspira pilosicoli, Enteric Pathogen of Animals and Humans.

Authors:  David J Hampson
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

2.  Human intestinal spirochetosis mimicking ulcerative colitis.

Authors:  Shin Nishii; Masaaki Higashiyama; Sho Ogata; Shunsuke Komoto; Suguru Ito; Akinori Mizoguchi; Hisato Terada; Hirotaka Furuhashi; Takeshi Takajo; Kazuhiko Shirakabe; Chikako Watanabe; Kengo Tomita; Shigeaki Nagao; Soichiro Miura; Ryota Hokari
Journal:  Clin J Gastroenterol       Date:  2017-12-04

3.  Human Intestinal Spirochetosis Incompatible With Dysplastic Adenomatous Epithelium.

Authors:  Cullen Lilley; Joseph Grech; Emily Martinbianco; Xiuxu Chen
Journal:  Cureus       Date:  2022-03-14

4.  Changes in the intestine microbial, digestion and immunity of Litopenaeus vannamei in response to dietary resistant starch.

Authors:  Yafei Duan; Yun Wang; Qingsong Liu; Hongbiao Dong; Hua Li; Dalin Xiong; Jiasong Zhang
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

5.  Functional diversity of microbial ecologies estimated from ancient human coprolites and dental calculus.

Authors:  David K Jacobson; Tanvi P Honap; Cara Monroe; Justin Lund; Brett A Houk; Anna C Novotny; Cynthia Robin; Elisabetta Marini; Cecil M Lewis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-10-05       Impact factor: 6.237

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.